September 1 | 2022
2cureX expands distribution of IndiTreat® to Romania
Read more
August 25 | 2022
2cureX publishes interim report for the second quarter and first half of 2022
Read more
August 25 | 2022
2cureX offentliggör delårsrapport för det andra kvartalet och första halvåret 2022
Read more
August 22 | 2022
Invitation to 2cureX Webcast on August 25, 2022.
Read more
August 8 | 2022
Announcement from 2cureX extra general meeting
Read more
August 8 | 2022
Kommuniké från extra bolagsstämma i 2cureX
Read more
July 20 | 2022
Notice of extra general meeting in 2cureX AB
Read more
July 20 | 2022
Kallelse till extra bolagsstämma i 2curex AB
Read more
July 1 | 2022
Dr. Raphael Gruber joins 2cureX as new Medical Director
Read more
June 28 | 2022
2cureX expands distribution of IndiTreat® to Israel
Read more
June 7 | 2022
2cureX AB announces share purchase by the company’s Chairman of the Board of Directors and Executive Management
Read more
May 31 | 2022
Strengthening the IndiTreat® distribution in North Europe
Read more
May 24 | 2022
Kommuniké från årsstämma i 2cureX AB
Read more
May 24 | 2022
2cureX publishes interim report for the first quarter 2022
Read more
May 24 | 2022
2cureX offentliggör delårsrapport för det första kvartalet 2022
Read more
May 20 | 2022
We invite you to join the 2cureX Q1 Report webcast and Q&A session at 15:00 on 24 May, 2022
Read more
May 17 | 2022
Three IndiTreat® posters have been accepted at ESMO-GI 2022
Read more
May 12 | 2022
2cureX AB nominates Dr. Michael Schaefer to the Board of Directors
Read more